These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 6321751)

  • 1. Attachment of Sendai virus particles to cell membranes: dissociation of adsorbed virus particles with dithiothreitol.
    Chejanovsky N; Beigel M; Loyter A
    J Virol; 1984 Mar; 49(3):1009-13. PubMed ID: 6321751
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sendai virus-erythrocyte membrane interaction: quantitative and kinetic analysis of viral binding, dissociation, and fusion.
    Hoekstra D; Klappe K
    J Virol; 1986 Apr; 58(1):87-95. PubMed ID: 3005662
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fusion of Sendai virions or reconstituted Sendai virus envelopes with liposomes or erythrocyte membranes lacking virus receptors.
    Citovsky V; Loyter A
    J Biol Chem; 1985 Oct; 260(22):12072-7. PubMed ID: 2995357
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Osmotic swelling allows fusion of sendai virions with membranes of desialyzed erythrocytes and chromaffin granules.
    Citovsky V; Laster Y; Schuldiner S; Loyter A
    Biochemistry; 1987 Jun; 26(13):3856-64. PubMed ID: 2820480
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protein blot analysis of virus receptors: identification and characterization of the Sendai virus receptor.
    Gershoni JM; Lapidot M; Zakai N; Loyter A
    Biochim Biophys Acta; 1986 Mar; 856(1):19-26. PubMed ID: 3006771
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sendai virus envelope glycoproteins become laterally mobile on the surface of human erythrocytes following fusion.
    Henis YI; Gutman O; Loyter A
    Exp Cell Res; 1985 Oct; 160(2):514-26. PubMed ID: 2995100
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of virus-attached antibodies or insulin molecules to mediate fusion between Sendai virus envelopes and neuraminidase-treated cells.
    Gitman AG; Kahane I; Loyter A
    Biochemistry; 1985 May; 24(11):2762-8. PubMed ID: 2992575
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Construction of fusogenic vesicles bearing specific antibodies. Targeting of reconstituted Sendai virus envelopes towards neuraminidase-treated human erythrocytes.
    Gitman AG; Loyter A
    J Biol Chem; 1984 Aug; 259(15):9813-20. PubMed ID: 6086652
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunofluorescence and electron microscopy of the cytoplasmic surface of the human erythrocyte membrane and its interaction with Sendai virus.
    Büechi M; Bächi T
    J Cell Biol; 1979 Nov; 83(2 Pt 1):338-47. PubMed ID: 227914
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interaction between Sendai virus and the cell membranae I. Restricted number of Sendai virus particles engaged in fusion with chicken red cell membrane.
    Yasuda H; Shimizu K; Ishida N
    Acta Virol; 1980 Mar; 24(2):89-97. PubMed ID: 6107031
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The use of specific antibodies to mediate fusion between Sendai virus envelopes and living cells.
    Loyter A; Tomasi M; Gitman AG; Etinger L; Nussbaum O
    Ciba Found Symp; 1984; 103():163-80. PubMed ID: 6323106
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adsorption of LLCMK2 cell-grown Sendai virus onto human red blood cells and its release from the virus adsorbed cells.
    Komatsu H; Tozawa H
    Microbiol Immunol; 1988; 32(12):1201-10. PubMed ID: 2853288
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of the fusogenic properties of Sendai virus: kinetics of fusion with erythrocyte membranes.
    Hoekstra D; Klappe K; de Boer T; Wilschut J
    Biochemistry; 1985 Aug; 24(18):4739-45. PubMed ID: 3000417
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interaction between Sendai virus and the cell membrane II. The role of Sendai virus neuraminidase in haemolysis.
    Yasuda H; Shimizu K; Ishida N
    Acta Virol; 1980 Mar; 24(2):98-104. PubMed ID: 6107032
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reconstitution and fusogenic properties of Sendai virus envelopes.
    Harmsen MC; Wilschut J; Scherphof G; Hulstaert C; Hoekstra D
    Eur J Biochem; 1985 Jun; 149(3):591-9. PubMed ID: 2408889
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The interaction between Sendai virus and cell membranes. A quantitative analysis of 125I-sendai virus particles' association with human red blood cells.
    Wolf D; Kahana I; Nir S; Loyter A
    Exp Cell Res; 1980 Dec; 130(2):361-9. PubMed ID: 6256188
    [No Abstract]   [Full Text] [Related]  

  • 17. Kinetics and extent of fusion between Sendai virus and erythrocyte ghosts: application of a mass action kinetic model.
    Nir S; Klappe K; Hoekstra D
    Biochemistry; 1986 Apr; 25(8):2155-61. PubMed ID: 3011079
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Active function of membrane receptors for enveloped viruses. I. Specific requirement for liposome-associated sialoglycolipids, but not sialoglycoproteins, to allow lysis of phospholipid vesicles by reconstituted Sendai viral envelopes.
    Citovsky V; Zakai N; Loyter A
    Exp Cell Res; 1986 Oct; 166(2):279-94. PubMed ID: 3017741
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Animal viruses are able to fuse with prokaryotic cells. Fusion between Sendai or influenza virions and Mycoplasma.
    Citovsky V; Rottem S; Nussbaum O; Laster Y; Rott R; Loyter A
    J Biol Chem; 1988 Jan; 263(1):461-7. PubMed ID: 2826447
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selective extraction of biologically active F-glycoprotein from dithiothreitol reduced Sendai virus particles.
    Tomasi M; Loyter A
    FEBS Lett; 1981 Aug; 131(2):381-5. PubMed ID: 6271578
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.